Breaking Finance News

Concepta Plc (LON:CPT) has been retained to Speculative Buy in a statement by Beaufort Securities earlier today.

Beaufort Securities has retained Concepta Plc (LON:CPT) to Speculative Buy in a statement released on 09/22/2016.

Having a price of 17.75GBX, Concepta Plc (LON:CPT) traded 5.41% higher on the day. With the last close up 22.90% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Concepta Plc has recorded a 50-day average of 15.53GBX and a two hundred day average of 15.87GBX. Volume of trade was down over the average, with 391,534 shares of CPT changing hands under the typical 625,650

Performance Chart

Concepta Plc (LON:CPT)

With a total market value of 0 GBX, Concepta Plc has with a one year low of 8.25GBX and a one year high of 80.00GBX .

More About Concepta Plc (LON:CPT)

Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women's fertility and unexplained infertility. The Company's portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App. MyLotus Meter addresses the issue of timing of intercourse in relation to the women's fertility hormones. It can detect the actual concentration of the hormones in a woman's urine sample allowing detailed analysis of issues with ovulation and fertility. Ovulation Test indicates whether or not the women's period is about to start, and also the concentration of lutenising hormone (LH) in the urine. Pregnancy Test measures the level of human chorionic gonadotrophin (hCG), a hormone produced during pregnancy, in urine. Fertility App is a downloadable application that allows women to track fertility on mobile.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *